ASCO recap: Myeloma moves, ADC advances & brain cancer progress

The latest stories trending on MedCity News.

Editor's Pick

Top Story ASCO Recap: Multiple Myeloma Moves, ADC Advances & Brain Cancer Progress During the annual meeting of the American Society of Clinical Oncology, a cell therapy posted clinical data during that could broaden its use in multiple myeloma. In other developments, the class of drugs called ADCs continue to make progress and a novel brain cancer drug has Phase 3 data that support its use as a new treatment option. Sponsored Content The Challenges of Temperature Controlled Logistics and How to Overcome Them Presented by MedCity News & YSDS Life Sciences With more freight moving around the world than ever, there's never been such pressure on the success of temperature controlled logistics as there is now. Learn expert tips to help you navigate temperature controlled logistics. Read More>>

Featured News

PE Investments, Acquisitions Fuel New Stages of Growth for Healthcare and Life Science Companies In an interview, Nathan Ray, a partner with the healthcare and life practice who oversees M&A/PE related work in that industry for West Monroe, highlighted how his firm works with companies to drive due diligence for clients, and help acquired companies address issues and differentiate during holds,. Better Predicting Drug Safety Calms Quarrels Between Medical Needs & Regulatory Process Human tissues, coupled with AI that can deal with terabytes of data will blow mice models out of the water. With animal testing requirements finally removed, the pharma industry and its constituents can hope for faster innovation. Meet the Company Building the First-Ever Noninvasive Blood Glucose Monitoring Device Know Labs recently unveiled the prototype for its non-invasive, portable glucose monitoring device. The device incorporates the company's proprietary body-radio frequency identification (Bio-RFID) technology — meaning its sensors deploy radio waves that travel through the skin to find and measure molecular signatures in the blood. CMS Tests New Primary Care Model in 8 States The Making Care Primary Model will be tested by the Center for Medicare and Medicaid Innovation from July 1, 2024, to December 31, 2034, in Colorado, Massachusetts, Minnesota, New Jersey, New Mexico, New York, North Carolina and Washington.

Resources

MedCity Pivot Podcast: It's Time To Talk About Responsible AI In this episode of the Pivot podcast,  we spoke with Suchi Saria, associate professor of medicine at John Hopkins University and director of its Machine Learning and Healthcare Lab. She is also CEO of Bayesian Health. Saria has spent a lot of time researching responsible AI and how to develop a framework for its adoption in healthcare. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe